Evidence map›Paper›PMID 33128820›Full record

ArticleInternational journal of cancer2021

Association between anthropometry and lifestyle factors and risk of B-cell lymphoma: An exposome-wide analysis.

Fatemeh Saberi Hosnijeh, Delphine Casabonne, Alexandra Nieters, Marta Solans, Sabine Naudin, Pietro Ferrari, James D Mckay, Yolanda Benavente, Elisabete Weiderpass, Heinz Freisling and 25 more

Open access · hybridAbstract read
In one paragraph

Article in International journal of cancer, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. What is next for occupational cancer epidemiology?Scandinavian journal of work, environment & health · 2022
    Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

35 authors at 20 institutions in 9 countries.

Fatemeh Saberi HosnijehDivision of Environmental Epidemiology, Institute for Risk Assessment Sciences, Utrecht University, Utrecht, The Netherlands.ORCID 0000-0002-7572-9715
Delphine CasabonneUnit of Infections and Cancer, Cancer Epidemiology Research Programme, IDIBELL, Catalan Institute of Oncology, Badalona, Spain.ORCID 0000-0002-7874-3707
Alexandra NietersInstitute for Immunodeficiency, Faculty of Medicine and Medical Center, University of Freiburg, Freiburg, Germany.
Marta SolansCentro de Investigación Biomédica en Red: Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Sabine NaudinNutritional Methodology and Biostatistics Group, International Agency for Research on Cancer, World Health Organization, Lyon, France.ORCID 0000-0003-1049-6225
Pietro FerrariNutritional Methodology and Biostatistics Group, International Agency for Research on Cancer, World Health Organization, Lyon, France.ORCID 0000-0001-9358-7338
James D MckaySection of Genetics, International Agency for Research on Cancer, Lyon, France.
Yolanda BenaventeUnit of Infections and Cancer, Cancer Epidemiology Research Programme, IDIBELL, Catalan Institute of Oncology, Badalona, Spain.
Elisabete WeiderpassInternational Agency for Research on Cancer, World Health Organization, Lyon, France.ORCID 0000-0003-2237-0128
Heinz FreislingNutritional Methodology and Biostatistics Group, International Agency for Research on Cancer, World Health Organization, Lyon, France.
Gianluca SeveriUniversité Paris-Saclay, UVSQ, CESP U1018 INSERM, Villejuif, France.ORCID 0000-0001-7157-419X
Marie-Christine Boutron RuaultUniversité Paris-Saclay, UVSQ, CESP U1018 INSERM, Villejuif, France.ORCID 0000-0002-5956-5693
Caroline BessonUniversité Paris-Saclay, UVSQ, CESP U1018 INSERM, Villejuif, France.ORCID 0000-0003-4364-7173
Claudia AgnoliEpidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Giovanna MasalaCancer Risk Factors and Life-Style Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network-ISPRO, Florence, Italy.
Carlotta SacerdoteUnit of Cancer Epidemiology, Città della Salute e della Scienza University-Hospital and Center for Cancer Prevention (CPO), Turin, Italy.ORCID 0000-0002-8008-5096
Rosario TuminoCancer Registry and Histopathology Department, Azienda Sanitaria Provinciale, Ragusa, Italy.
José María HuertaDepartment of Epidemiology, Murcia Regional Health Council, IMIB-Arrixaca, Murcia, Spain.
Pilar AmianoPublic Health Division of Gipuzkoa, BioDonostia Research Institute, San Sebastian; CIBER Epidemiología y Salud Pública, Madrid, Spain.
Miguel Rodriguez-BarrancoEscuela Andaluza de Salud Pública (EASP), Granada, Spain.
Catalina BonetUnit of Nutrition and Cancer, Catalan Institute of Oncology-ICO, Nutrition and Cancer Group, Bellvitge Biomedical Research Institute-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.
Aurelio BarricarteCentro de Investigación Biomédica en Red: Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Sofia ChristakoudiDepartment of Epidemiology and Biostatistics, Imperial College London, London, UK.ORCID 0000-0001-9219-4436
Anika KnuppelCancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
Bas Bueno-de-MesquitaDepartment for Determinants of Chronic Diseases, National Institute for Public Health and the Environment (RIVM), The Netherlands.
Matthias B SchulzeDepartment of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany.
Rudolf KaaksDivision of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Federico CanzianResearch Group Genomic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Florentin SpäthDepartment of Radiation Sciences, Oncology and Cancer center, Department of Hematology, Umeå University, Umeå, Sweden.
Mats JerkemanDepartment of Oncology, Lund University, Lund, Sweden.
Charlotta RylanderDepartment of Public Health, University of Copenhagen, Copenhagen, Denmark.
Anne TjønnelandDepartment of Public Health, University of Copenhagen, Copenhagen, Denmark.
Anja OlsenDanish Cancer Society Research Center, Copenhagen, Denmark.
Kristin Benjaminsen BorchDepartment of Community Medicine, UiT, The Arctic University of Norway, Tromsø, Norway.
Roel VermeulenDivision of Environmental Epidemiology, Institute for Risk Assessment Sciences, Utrecht University, Utrecht, The Netherlands.
Centre international de recherche sur le cancer · FRInserm · FRGerman Cancer Research Center · DEInstitut Català d'Oncologia · ESPiedmont Reference Center for Epidemiology and Cancer Prevention · ITUniversity of Copenhagen · DKUtrecht University · NLAgenzia Regionale Sanitaria della Puglia · ITBiogipuzkoa Health Research Institute · ESDanish Cancer Society · DKFondazione IRCCS Istituto Nazionale dei Tumori · ITInstitut d'Investigació Biomédica de Bellvitge · ESInstituto de Investigación Biosanitaria de Granada · ESInstituto de Salud Pública de Navarra · ESInstituto Murciano de Investigación Biosanitaria · ESKing's College London · GBLund University · SEUiT The Arctic University of Norway · NOUmeå University · SEUniversitat de Girona · ES

Funding

Cancer Research UK 14136Cancer Research UK 14136 (to EPIC-Norfolk)Cancer Research UK C570/A11692Cancer Research UK C570/A16491Medical Research Council 1000143 (to EPIC-Norfolk)Medical Research Council G0401527Medical Research Council G1000143Medical Research Council MR/M012190/1Medical Research Council MR/M012190/1 (to EPIC-Oxford)Medical Research Council MR/N003284/1Wellcome TrustWellcome Trust 205212/Z/16/ZWorld Health Organization 001
6 · The paper itself

Abstract

To better understand the role of individual and lifestyle factors in human disease, an exposome-wide association study was performed to investigate within a single-study anthropometry measures and lifestyle factors previously associated with B-cell lymphoma (BCL). Within the European Prospective Investigation into Cancer and nutrition study, 2402 incident BCL cases were diagnosed from 475 426 participants that were followed-up on average 14 years. Standard and penalized Cox regression models as well as principal component analysis (PCA) were used to evaluate 84 exposures in relation to BCL risk. Standard and penalized Cox regression models showed a positive association between anthropometric measures and BCL and multiple myeloma/plasma cell neoplasm (MM). The penalized Cox models additionally showed the association between several exposures from categories of physical activity, smoking status, medical history, socioeconomic position, diet and BCL and/or the subtypes. PCAs confirmed the individual associations but also showed additional observations. The PC5 including anthropometry, was positively associated with BCL, diffuse large B-cell lymphoma (DLBCL) and MM. There was a significant positive association between consumption of sugar and confectionary (PC11) and follicular lymphoma risk, and an inverse association between fish and shellfish and Vitamin D (PC15) and DLBCL risk. The PC1 including features of the Mediterranean diet and diet with lower inflammatory score showed an inverse association with BCL risk, while the PC7, including dairy, was positively associated with BCL and DLBCL risk. Physical activity (PC10) was positively associated with DLBCL risk among women. This study provided informative insights on the etiology of BCL.

Indexed as

AnthropometryCohort StudiesExposomeFemaleHumansLife StyleLymphoma, B-CellMaleMiddle AgedProspective StudiesRisk Factorsexposomeexposome-wide association studylifestylelymphomaprospective study

Identifiers

PMID33128820
PMCPMC8048490
OpenAlexW3096621709

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.